Xenon Pharmaceuticals Inc (XENE)
Working Capital Ratio
69.52%
Quarterly · Period ending:
XENE Working Capital Ratio
Latest reported69.52%period ending
Latest reported69.52%period ending
XENE Quarterly Working Capital Ratio (65.57% → 69.52%)
Quarterly working capital ratio
High-resolution chart · PNG
XENE working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 69.523% | |
| 76.926% | |
| 52.8545% | |
| 72.6844% | |
| 69.2894% | |
| 71.7774% | |
| 75.134% | |
| 75.3611% | |
| 78.823% | |
| 74.5336% | |
| 64.0226% | |
| 75.4387% | |
| 75.4063% | |
| 70.9658% | |
| 76.5894% | |
| 81.6742% | |
| 96.7409% | |
| 96.34% | |
| 95.2258% | |
| 92.0958% | |
| 91.6501% | |
| 93.4968% | |
| 88.274% | |
| 89.336% | |
| 88.2659% | |
| 78.1909% | |
| 68.713% | |
| 85.7205% | |
| 88.765% | |
| 92.2488% | |
| 95.8261% | |
| 95.8798% | |
| 93.6121% | |
| 87.0531% | |
| 88.3285% | |
| 90.4441% | |
| 90.1025% | |
| 91.3862% | |
| 92.1051% | |
| 91.8265% | |
| 90.619% | |
| 90.5874% | |
| 90.8286% | |
| 86.8952% | |
| 81.4575% | |
| 84.1228% | |
| 80.8255% | |
| 58.965% | |
| 55.1684% | |
| 58.1166% | |
| 62.3536% | |
| 62.3536% | |
| 65.5667% | |
| 65.5667% |